Abstract
With the rise of multidrug resistant bacteria and a growing number of nosocomial infections, there has been an increased interest in finding new antibacterial drugs and drug targets. Riboswitches represent attractive new antibacterial drug targets, because they not only inherently recognize a specific metabolite or ion with their RNA aptamer domain, but also often regulate essential metabolic pathways. Here, we describe a reporter gene-based screen to identify compounds that activate the thiamine pyrophosphate (TPP) riboswitch in bacteria. This assay can be easily adapted for different riboswitch classes and thus has the potential to target many essential metabolic pathways and a broad spectrum of bacterial pathogens.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Breaker RR (2011) Prospects for riboswitch discovery and analysis. Mol Cell 43(6):867–879. doi:10.1016/j.molcel.2011.08.024
Blount KF, Breaker RR (2006) Riboswitches as antibacterial drug targets. Nat Biotechnol 24(12):1558–1564. doi:10.1038/nbt1268
Lünse CE, Schüller A, Mayer G (2014) The promise of riboswitches as potential antibacterial drug targets. Int J Med Microbiol 304(1):79–92. doi:10.1016/j.ijmm.2013.09.002
Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR (2007) Antibacterial lysine analogs that target lysine riboswitches. Nat Chem Biol 3(1):44–49. doi:10.1038/nchembio842
Lünse CE, Schmidt MS, Wittmann V, Mayer G (2011) Carba-sugars activate the glmS-riboswitch of Staphylococcus aureus. ACS Chem Biol 6(7):675–678. doi:10.1021/cb200016d
Lünse CE, Scott FJ, Suckling CJ, Mayer G (2014) Novel TPP-riboswitch activators bypass metabolic enzyme dependency. Front Chem 2:53. doi:10.3389/fchem.2014.00053
Blount KF, Megyola C, Plummer M, Osterman D, O'Connell T, Aristoff P, Quinn C, Chrusciel RA, Poel TJ, Schostarez HJ, Stewart CA, Walker DP, Wuts PG, Breaker RR (2015) Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora. Antimicrob Agents Chemother 59(9):5736–5746. doi:10.1128/AAC.01282-15
Kim JN, Blount KF, Puskarz I, Lim J, Link KH, Breaker RR (2009) Design and antimicrobial action of purine analogues that bind Guanine riboswitches. ACS Chem Biol 4(11):915–927. doi:10.1021/cb900146k
Mulhbacher J, Brouillette E, Allard M, Fortier LC, Malouin F, Lafontaine DA (2010) Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathog 6(4), e1000865. doi:10.1371/journal.ppat.1000865
Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T (2015) Selective small-molecule inhibition of an RNA structural element. Nature 526(7575):672–677. doi:10.1038/nature15542
Winkler W, Nahvi A, Breaker RR (2002) Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 419(6910):952–956. doi:10.1038/nature01145
Miller JH (1992) A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Plainview, NY
Nelson JW, Plummer MS, Blount KF, Ames TD, Breaker RR (2015) Small molecule fluoride toxicity agonists. Chem Biol 22(4):527–534. doi:10.1016/j.chembiol.2015.03.016
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2(2006):0008. doi:10.1038/msb4100050
Simons RW, Houman F, Kleckner N (1987) Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53(1):85–96
Mayer G, Raddatz MS, Grunwald JD, Famulok M (2007) RNA ligands that distinguish metabolite-induced conformations in the TPP riboswitch. Angew Chem Int Ed Engl 46(4):557–560. doi:10.1002/anie.200603166
Tang X, Nakata Y, Li HO, Zhang M, Gao H, Fujita A, Sakatsume O, Ohta T, Yokoyama K (1994) The optimization of preparations of competent cells for transformation of E. coli. Nucleic Acids Res 22(14):2857–2858
Rentmeister A, Mayer G, Kuhn N, Famulok M (2007) Conformational changes in the expression domain of the Escherichia coli thiM riboswitch. Nucleic Acids Res 35(11):3713–3722. doi:10.1093/nar/gkm300
Acknowledgments
G.M. was supported by a grant from the German Research Foundation (MA3442/1-2). C.E.L. was supported by the German Research Foundation grant LU1889-1 and NIH P01 grant GM022778 awarded to Professor Ronald R. Breaker, HHMI investigator, Yale University.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lünse, C.E., Mayer, G. (2017). Reporter Gene-Based Screening for TPP Riboswitch Activators. In: Sass, P. (eds) Antibiotics. Methods in Molecular Biology, vol 1520. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6634-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6634-9_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6632-5
Online ISBN: 978-1-4939-6634-9
eBook Packages: Springer Protocols